Therapy Management Software for Naturalistic Model-Based Behavioral Interventions
基于自然模型的行为干预的治疗管理软件
基本信息
- 批准号:8686959
- 负责人:
- 金额:$ 34.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptionAgeAutistic DisorderBehavior TherapyBehavioralCaringChildCognitiveCommunitiesComputer softwareDataData CollectionData ReportingDevelopmentDoctor of PhilosophyEducational CurriculumEnvironmentFeasibility StudiesFeedbackFocus GroupsGroup MeetingsHourIndividualInterventionLearningLibrariesLifeModelingMonitorOutcomePhaseProviderQuality of lifeRepetitive SequenceReportingResearchResearch PersonnelSmall Business Innovation Research GrantSocietiesStagingStructureSystemTabletsTechniquesTimeTrainingTreatment CostUniversitiesWashingtonautism spectrum disorderbasecomparative effectivenesscostdesignevidence baseflexibilityimprovedinnovationprogramsprototypepublic health relevancerepositorytherapy designtool
项目摘要
DESCRIPTION (provided by applicant): This Phase I SBIR resubmission proposes to develop a prototype of a major new type of therapy management software for autism therapy provider groups, which will enable them to deliver emerging types of behavioral interventions that are designed for treating very young children with Autism Spectrum Disorder (ASD). Studies have shown that therapy is most effective when treatment begins at ages 2-4, while cognitive abilities are in earlier stages of development. However, traditional autism therapy (Applied Behavioral Analysis) is not well- suited for children under 5, as it requires adherence to a linear sequence of repetitive therapist-directed trials for 20 or more hours a week. Over the past decade, autism researchers have developed and studied new types of intensive interventions that are rigorous and data-driven, yet appropriate for very young children. The lack of tools to facilitate these types of therapies in a team environment is a significant obstacle to their widespread adoption by traditional ABA therapy groups. Existing therapy management systems do not accommodate the creation or importing of structured models associated with these interventions, and their therapy delivery and data collection interfaces are too rigid to support the naturalistic therapy techniques that these interventions require. The software proposed herein will consist of three major innovations: (1) a Model Manager, which will allow a director to import a structured model, tailor it to fit her own practice approach, and use it as a template system that governs the creation of curriculums within her organization, (2) a Curriculum Builder, that will allow program managers to construct and refine individual therapy curriculums based on the director's prescribed model, and (3) a Therapy Driver tablet application that facilitates naturalistic, child-
directed implementation of the prescribed curriculum, including an activity-based task prompter, a real-time learning step tuner, and an alert-driven therapy coverage indicator. This proposal will
allow us to complete the design and implementation of a fully operational prototype, with iterative feedback from autism intervention researchers at the University of Washington, and conduct a feasibility study by deploying Abacus to a large community therapy provider (Northwest Behavioral Associates) who will use it to deliver a naturalistic model- based therapy to young children while observers determine whether or not 14 key functions are achieved. At the end of Phase I, we will have developed a mature prototype of software with the potential to accelerate the adoption of emerging behavioral interventions. As such, it has the potential to be highly significant, as widespread adoption of new evidence-based therapies will improve long-term outcomes for many people with ASD, enabling them to live more independently, and saving society billions of dollars in reduced costs of care.
描述(由申请人提供):这项第一阶段的SBIR重新提交建议为自闭症治疗提供者群体开发一个主要的新型治疗管理软件的原型,这将使他们能够提供旨在治疗患有自闭症谱系障碍(ASD)的非常年幼的儿童的新兴类型的行为干预。研究表明,治疗在2-4岁开始治疗时最有效,而认知能力处于早期发展阶段。然而,传统的自闭症治疗(应用行为分析)并不适合5岁以下的儿童,因为它需要坚持一系列由治疗师指导的线性重复试验,每周20小时或更长时间。在过去的十年里,自闭症研究人员开发和研究了新型的强化干预措施,这种干预措施严格且以数据为导向,但适合非常年幼的儿童。缺乏在团队环境中促进这些类型的治疗的工具是传统ABA治疗小组广泛采用它们的一个重大障碍。现有的治疗管理系统不适合创建或导入与这些干预措施相关的结构化模型,其治疗交付和数据收集接口过于僵化,无法支持这些干预措施所需的自然治疗技术。本文提出的软件将由三个主要创新组成:(1)模型管理器,它将允许导演导入结构化模型,将其定制以适合她自己的练习方法,并将其用作管理其组织内的课程创建的模板系统;(2)课程构建器,其将允许项目经理根据导演规定的模型来构建和改进个人治疗课程;以及(3)治疗驱动平板应用程序,其促进自然主义、儿童-
指导实施规定的课程,包括基于活动的任务提示器、实时学习步骤调谐器和警报驱动的治疗覆盖率指示器。这项提议将
通过华盛顿大学自闭症干预研究人员的迭代反馈,允许我们完成完全可操作的原型的设计和实施,并通过将Abacus部署到大型社区治疗提供商(西北行为协会)进行可行性研究,后者将使用它为幼儿提供基于自然模型的治疗,而观察者将确定是否实现了14项关键功能。在第一阶段结束时,我们将开发一个成熟的软件原型,有可能加速采用新兴的行为干预。因此,它有可能具有非常重要的意义,因为广泛采用新的循证疗法将改善许多自闭症患者的长期结果,使他们能够更独立地生活,并为社会节省数十亿美元的护理成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
REX M JAKOBOVITS其他文献
REX M JAKOBOVITS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('REX M JAKOBOVITS', 18)}}的其他基金
Acuity - A Clinical Decision Support System for Applied Behavior Analysis
Acuity - 应用行为分析的临床决策支持系统
- 批准号:
10552494 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
Acuity - A Clinical Decision Support System for Applied Behavior Analysis
Acuity - 应用行为分析的临床决策支持系统
- 批准号:
10681393 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
Goalspace: A Platform for Parent-Assisted Behavioral Interventions
Goalspace:家长辅助行为干预平台
- 批准号:
10674912 - 财政年份:2020
- 资助金额:
$ 34.16万 - 项目类别:
Goalspace: A Platform for Parent-Assisted Behavioral Interventions
Goalspace:家长辅助行为干预平台
- 批准号:
10082395 - 财政年份:2020
- 资助金额:
$ 34.16万 - 项目类别:
Goalspace: A Platform for Parent-Assisted Behavioral Interventions
Goalspace:家长辅助行为干预平台
- 批准号:
10207442 - 财政年份:2020
- 资助金额:
$ 34.16万 - 项目类别:
V-Motive: System for Comprehensive Therapy-Integrated Video Modeling
V-Motive:综合治疗集成视频建模系统
- 批准号:
9117633 - 财政年份:2015
- 资助金额:
$ 34.16万 - 项目类别:
V-Motive: System for Comprehensive Therapy-Integrated Video Modeling
V-Motive:综合治疗集成视频建模系统
- 批准号:
9361110 - 财政年份:2015
- 资助金额:
$ 34.16万 - 项目类别:
Therapy Management Software for Naturalistic Model-Based Behavioral Interventions
基于自然模型的行为干预的治疗管理软件
- 批准号:
8523685 - 财政年份:2013
- 资助金额:
$ 34.16万 - 项目类别:
BioSCRIBE: Collaborative Experiment Management Software
BioSCRIBE:协作实验管理软件
- 批准号:
6930594 - 财政年份:2004
- 资助金额:
$ 34.16万 - 项目类别:
BioSCRIBE: Collaborative Experiment Management Software
BioSCRIBE:协作实验管理软件
- 批准号:
6738747 - 财政年份:2004
- 资助金额:
$ 34.16万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Fellowship Programs